References
- Martins SS, Sarvet A, Santaella-Tenorio J, et al. Changes in US lifetime heroin use and heroin use disorder. JAMA Psychiatry. 2017;74(5):445–455.
- Substance Abuse and Mental Health Services Administration (SAMHSA). Results from the 2012 National Survey on Drug Use and Health: summary of national findings. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2013. NSDUH Series H-46, HHS Publication No. (SMA), p 13–4795. Retrieved from: http://www.samhsa.gov/data/sites/default/files/NSDUHresults2012/NSDUHresults2012.pdf
- Substance Abuse and Mental Health Services Administration (SAMHSA), Center for Behavioral Health Statistics and Quality. Treatment Episode Data Set (TEDS): 2003-2013. National Admissions to Substance Abuse Treatment Services. Rockville, MD: Substance Abuse and Mental Health Services Administration (SAMHSA); 2015. BHSIS Series S-76, HHS Publication No. (SMA), p 15-4934. Retrieved from: https://www.samhsa.gov/data/sites/default/files/2013_Treatment_Episode_Data_Set_National/2013_Treatment_Episode_Data_Set_National.pdf
- Rudd RA, Seth P, David F, et al. Increases in drug and opioid-involved overdose deaths – United States, 2010-2015. MMWR Morb Mortal Wkly Rep. 2016;65(5051):1445–1452.
- Arfken CL. Drug Abuse in Detroit, Wayne County, and Michigan: 2011. Epidemiologic Trends in Drug Abuse: Proceedings of the Community Epidemiology Work Group. Bethesda, MD: National Institute of Drug Abuse; 2012:122–129.
- Artigiani E, Wish ED. Patterns and Trends of Drug Abuse in Baltimore/Maryland/Washington, DC, Metropolitan Area: Epidemiology and Trends 2002-2011. Epidemiologic Trends in Drug Abuse: proceedings of the Community Epidemiology Work Group. Bethesda, MD: National Institute of Drug Abuse; 2012:17–40.
- Israel H. Patterns and Trends in Drug Abuse in St. Louis, Missouri: 2011. Epidemiologic Trends in Drug Abuse: Proceedings of the Community Epidemiology Work Group. Bethesda, MD: National Institute of Drug Abuse; 2012:250–261.
- U.S. Census Bureau. American Community Survey 1-year estimates: United States. U.S. Census Bureau; 2016. Retrieved from Census Reporter Profile page for Detroit, MI: https://censusreporter.org/profiles/16000US2622000-detroit-mi
- U.S. Census Bureau. American Community Survey 1-year estimates: Detroit. U.S. Census Bureau; 2016. Retrieved from Census Reporter Profile page for United States: https://censusreporter.org/profiles/01000US-united-states
- Martinez ME, Ward BW. Health Care Access and Utilization among Adults Aged 18–64, by Poverty Level: United States, 2013–2015. Hyatsville, MD: National Center for Health Statistics; 2016. NCHS data brief, no 262.
- Rastogi S, Johnson TD, Hoeffel EM, et al. The Black population 2010: 2010 Census Briefs. United States Census Bureau; 2011. p 1–20.
- Lucas JW, Benson V. Tables of Summary Health Statistics for the U.S. Population: 2015 National Health Interview Survey. National Center for Health Statistics 2017; Retrieved from: http://www.cdc.gov/nchs/nhis/SHS/tables.htm
- Joe GW, Simpson DD, Hubbard RL. Treatment predictors of tenure in methadone maintenance. J Subst Abuse. 1991;3(1):73–84.
- Joe GW, Simpson DD, Broome KM. Effects of readiness for drug abuse treatment on client retention and assessment of process. Addiction. 1998;93:1177–1190.
- Lister JJ, Greenwald MK, Ledgerwood DM. Baseline risk factors for drug use among African-American patients during first-month induction/stabilization on methadone. J Subst Abuse Treat. 2017;78:15–21.
- Magura S, Nwakeze PC, Demsky S. Pre- and in-treatment predictors of retention in methadone treatment using survival analysis. Addiction. 1998;93:53–60.
- Proctor SL, Copeland AL, Kopak AM, et al. Predictors of patient retention in methadone maintenance treatment. Psychol Addict Behav. 2015;29(4):906–917.
- Saxon AJ, Wells EA, Fleming C, et al. Pre-treatment characteristics, program philosophy and level of ancillary services as predictors of methadone maintenance treatment outcome. Addiction. 1996;91(8):1197–1210.
- Amato L, Davoli M, Perucci CA, et al. An overview of systematic reviews of the effectiveness of opiate maintenance therapies: available evidence to inform clinical practice and research. J Subst Abuse Treat. 2005;28(4):321–329.
- Veilleux JC, Colvin PJ, Anderson J, et al. A review of opioid dependence treatment: pharmacological and psychosocial interventions to treat opioid addiction. Clin Psychol Rev. 2010;30(2):155–166.
- Levine AR, Lundahl LH, Ledgerwood DM, et al. Gender-specific predictors of retention and opioid abstinence during methadone maintenance treatment. J Subst Abuse Treat. 2015;54:37–43.
- Salamina G, Diecidue R, Vigna-Taglianti F, et al. Effectiveness of therapies for heroin addiction in retaining patients in treatment: results from the VEdeTTE Study. Subst Use Misuse 2010;45:2076–2092.
- Gryczynski J, Gwin-Mitchell S, Jaffe JH, et al. Retention in methadone and buprenorphine treatment among African Americans. J Subst Abuse Treat. 2013;45(3):287–292.
- Marsh JC, Cao D, Guerrero E, et al. Need-service matching in substance abuse treatment: racial/ethnic differences. Eval Program Plann. 2009;32(1):43–51.
- Griffith DM, Ellis KR, Allen JO. An intersectional approach to social determinants of stress for African American men: men’s and women’s perspectives. Am J Mens Health. 2013;7(4_suppl):19S–30S.
- Cole ER. Intersectionality and research in psychology. Am Psychol. 2009;64(3):170–180.
- Ferraro KF, Farmer MM. Double jeopardy to health hypothesis for African Americans: analysis and critique. J Health Soc Behav. 1996;37(1):27–43.
- Kelly SM, O’Grady KE, Mitchell SG, Brown BS, Schwartz RP. Predictors of methadone treatment retention from a multi-site study: a survival analysis. Drug Alcohol Depend. 2011;117(2-3):170–175.
- Peles E, Linzy S, Kreek MJ, et al. One-year and cumulative retention as predictors of success in methadone maintenance treatment: a comparison of two clinics in the United States and Israel. J Addict Dis. 2008;27(4):11–25.
- Schiff M, Levit S, Moreno RC. Retention and illicit drug use among methadone patients in Israel: a gender comparison. Addict Behav. 2007;32(10):2108–2119.
- Bawor M, Dennis BB, Anglin R, et al. Sex differences in outcomes of methadone maintenance treatment for opioid addiction: a systematic review protocol. Syst Rev. 2014;3:1–7.
- Greenfield SF, Brooks AJ, Gordon SM, et al. Substance abuse treatment entry, retention, and outcome in women: a review of the literature. Drug Alcohol Depend. 2007;86(1):1–21.
- Bawor M, Dennis BB, Varenbut M, et al. Sex differences in substance use, health, and social functioning among opioid users receiving methadone treatment: a multicenter cohort study. Biol Sex Differ 2015;6:1–11.
- Chatham LR, Hiller ML, Rowan-Szal GA, et al. Gender differences at admission and follow-up in a sample of methadone maintenance clients. Subst Use Misuse. 1999;34(8):1137–1165.
- Grella CE, Lovinger K. Gender differences in physical and mental health outcomes among an aging cohort of individuals with a history of heroin dependence. Addict Behav. 2012;37(3):306–312.
- American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Washington, DC: American Psychiatric Association; 2000. 4th ed.
- Baxter LE, Campbell A, DeShields M, et al. Safe methadone induction and stabilization: report of an expert panel. J Addict Med. 2013;7(6):377–386.
- Pollack HA, D'Aunno T. Dosage patterns in methadone treatment: results from a national survey, 1988–2005. Health Serv Res. 2008;43(6):2143–2163.
- Grant BF, Dawson DA. Age of onset of drug use and its association with DSM-IV drug abuse and dependence: results from the national longitudinal alcohol epidemiologic survey. J Subst Abuse. 1998;10(2):163–173.
- Allison PD. Multiple Regression: A Primer. Newbury Park, CA: Pine Forge Press; 1999. 1st ed.
- Bursac Z, Gauss CH, Williams DK, et al. Purposeful selection of variables in logistic regression. Source Code Biol Med. 2008;3:1–8.
- Rhoades HM, Creson D, Elk R, et al. Retention, HIV risk, and illicit drug use during treatment: methadone dose and visit frequency. Am J Public Health. 1998;88(1):34–39.
- Dolan KA, Shearer J, MacDonald M, et al. A rondmised controlled trial of methadone maintenance treatment versus wait list control in an Australian prison system. Drug Alcohol Depend. 2003;72(1):59–65.
- Kinlock TW, Gordon MS, Schwartz RP, et al. A randomized clinical trial of methadone maintenance for prisoners: results at 1-month post-release. Drug Alcohol Depend. 2007;91(2-3):220–227.
- Gruber VA, Delucchi KL, Kielstein A, et al. A randomized trial of 6-month methadone maintenance with standard or minimal counseling versus 21-day methadone detoxification. Drug Alcohol Depend. 2008;94(1-3):199–206.
- Savage A, Savage A, Russell LA. Tangled in a web of affiliation. J Behav Health Serv Res. 2005;32(2):199–214.
- Sun AP. Relapse among substance-abusing women: components and processes. Subst Use Misuse. 2007;42(1):1–21.
- Falkin GP, Strauss SM. Social supporters and drug use enablers: a dilemma for women in recovery. Addict Behav. 2003;28(1):141–155.
- Brown S, Tracy EM, Jun MKy, Park H, Min MO. Personal network recovery enablers and relapse risks for women with substance dependence. Qual Health Res. 2015;25(3):371–385.
- El-Bassel N, Chen DR, Cooper D. Social support and social network profiles among women on methadone. Soc Serv Rev. 1998;72:379–491.
- Grella CE, Stein JA. Impact of program services on treatment outcomes on patients with comorbid mental and substance use disorders. PS. (7) 2006;57:1007–1015.
- Collins FS, Varmus H. New initiative on precision medicine. N Engl J Med. 2015;372(9):793–795.
- Elliott DE, Bjelajac P, Fallot RD, Markoff LS, Reed BG. Trauma-informed or trauma-denied: principles and implementation of trauma-informed services for women. J Community Psychol. 2005;33(4):461–477.
- Chermack ST, Bonar EE, Ilgen MA, et al. Developing an integrated violence prevention for men and women in treatment for substance use disorders. J Interpers Violence. 2017;32(4):581–603.
- Najavits L. Seeking Safety: A Treatment Manual for PTSD and Substance Abuse. New York: Guilford Press; 2002.
- Tavakoli E, Moses TE, Deal E, et al. Predictors of retention and drug use among treatment-resistant patients transferred to a specialty “second chance” methadone maintenance program. Manuscript under review. 2018.
- Wade JC. Masculinity ideology, male reference group identity dependence, and African American men’s health-related attitudes and behaviors. Psychol Men Masculin. 2008;9(1):5–16.
- Petry NM, Martin B, Simcic F. Prize reinforcement contingency management for cocaine dependence: integration with group therapy in a methadone clinic. J Consult Psychol. 2005;73(2):354–359.
- Tzilos GK, Rhodes GL, Ledgerwood DM, et al. Predicting cocaine group treatment outcome in cocaine-abusing methadone patients. Exp Clin Psychopharmacol. 2009;17(5):320–325.
- National Institutes of Health. NIH-Wide Strategic Plan: Fiscal Years 2016–2020: turning Discovery into Health. Bethesda, MD: National Institutes of Health, U.S. Department of Health and Human Service; 2015. Retrieved from: https://www.nih.gov/sites/default/files/about-nih/strategic-plan-fy2016-2020-508.pdf
- D’Aunno T, Pollack HA. Changes in methadone treatment practices: results from a national panel study, 1988-2000. JAMA. 2002;288:850–856.